Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992
- 31 May 2000
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 36 (7), 901-908
- https://doi.org/10.1016/s0959-8049(00)00058-7
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patientsEuropean Journal of Cancer, 1997
- Childhood cancer in Britain: The National Registry of Childhood Tumours and incidence rates 1978–1987European Journal of Cancer, 1995
- Detection of bone marrow infiltration by neuroblastoma in clinical practice: How far have we come?European Journal of Cancer, 1994
- Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N–myc amplificationNature Genetics, 1993
- Late Recurrence of Neuroblastoma: A Report of Five Cases and Review of the LiteraturePediatric Hematology and Oncology, 1990
- STAGE AND URINARY CATECHOLAMINE METABOLITE EXCRETION IN NEUROBLASTOMAThe Lancet, 1989
- Ifosfamide in previously untreated disseminated neuroblastoma: Results of study 3A of the European Neuroblastoma Study GroupEuropean Journal of Cancer and Clinical Oncology, 1988
- Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastasesThe Journal of Pediatrics, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958